NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.
Leveraging Implementation Science to Optimize Strategies for Cancer Control in Mexico and Latin America We enrolled 55 patients with low grade lymphoma. Median age was 58 (range 28-82), 35 (64%) were ...
Sponsored advertising content is provided by Genmab A/S and AbbVie and does not necessarily reflect the views of CURE Each person’s experience with follicular lymphoma (FL) is unique. Whether you’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results